LYL273 for Patients With Relapsed or Refractory mCRC

Clinical trial NCT05319314 · RECRUITING

Trial details

NCT number: NCT05319314
Sponsor: Lyell Immunopharma, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2022-08-01
Primary completion: 2028-06-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.